AtTask Premium Customer Education Package

U.S. Department of Health & Human Services U.S. Food and Drug Administration Notice of Intent to Sole Source REQUISITION NO. 1115613 INTENDED SOURCE: AtTask, Inc. PERIOD of PERFORMANCE: 12 months PLACE OF PERFORMANCE: Silver Spring, Maryland NAICS CODE: 511210 DESCRIPTION OF REQUIREMENT: The US Food and Drug Administration, Office of Acquisitions and Grant Services intends to award a sole source acquisition for AtTask premium customer education program on behalf of the FDA's Center for Drug Evaluation and Research (CDER). The AtTask software is currently integrated into the CDER environment and this training program covers a wide spectrum of training services on the various functionalities of the software and is necessary in order for CDER to meet the mission of the FDA. The purpose of this procurement is to obtain the AtTask Customer Education training services that will facilitate FDA research. The proposed acquisition is for a product and related technical support services for which the government intends to solicit and negotiate with only one source. Interested parties may identify their interests and capabilities to respond to the requirement or submit quotes within fifteen (15) days after the date of publication of this notice. A determination by the government not to compete this proposed acquisition based upon responses to this notice is solely within the discretion of the government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive requirement. No further solicitation is available. All responsible vendors are encouraged to submit a response to this notice. FDA will consider all responses received prior to the closing date of this notice and will use responses in determining whether it is necessary to use full and open competition for this requirement. Please submit all information to Brendan McCarthy, Contracting Officer, by email at brendan.mccarthy@fda.hhs.gov and Patrick Gardner, Contracting Officer, by email at patrick.gardner@fda.hhs.gov.